Growth trajectory Target expansion in international markets leveraging established global presence in urology and orthopaedics, with recent product launches like the MASTERPULS R-SW series indicating momentum and potential for cross-selling ESWT and TPS/EMTT solutions.

Product diversification Opportunity to upsell adjacent therapeutic platforms such as TPS for neurology, AWT for aesthetic medicine, and EMTT for orthopaedics by highlighting integrated shock wave and transcranial modalities to clinics expanding into multi-discipline offering.

Private label potential With a compact size and established OEM partnerships under the KARL STORZ umbrella, pursue collaborations for private-label ESWT devices or modular systems to accelerate adoption in new regional markets and hospital procurement programs.

Clinical evidence push Capitalize on the company’s track record of clinical studies and real-world usage (e.g., retrospective ESWL study) by offering clinical collaboration, payer engagement, and outcomes-focused case packages to drive adoption among urology, orthopaedics, and rehabilitation groups.

Strategic partnerships Leverage recent collaborations such as Solaceum and ongoing neurology sessions to co-market advanced TPS and ESWT technologies, targeting neuroscience, geriatrics, and rehabilitation centers seeking non-invasive treatment alternatives.